🔴 Cue Biopharma is trading 10% down today after senior executives sold substantial shareholdings

Cue Biopharma is trading 9.99% down at $24.88 after an August 18 disclosure that senior executives sold substantial shareholdings.

• The legal chief sold $265,627, while a vice president disposed of $169,323.
• The stock fell 19.18% on August 17, extending a sharp reversal from its August 14 close of $34.20.
• Broader risk-off conditions are pressuring growth stocks: Nasdaq is down 1.42% and the S&P 500 is down 0.67%.